Entera Bio Ltd. (ENTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 89.61M |
| Enterprise Value | 82.99M |
| P/E Ratio | -4.59 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 5.41 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.53 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.94 |
| Return On Equity | -0.88 |
Income Statement
| Revenue | 42,000 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -11.41M |
| Net Income | -11.44M |
| Diluted EPS | -0.25 |
Balance Sheet
| Total Cash | 4.14M |
| Total Cash/Share | 0.09 |
| Total Debt | 448,000 |
| Total Debt/Equity | 0.04 |
| Current Ratio | 7.93 |
| Book Value Per Share | 0.22 |
Price History
| 52-Week Change | -38.27 |
| 52-Week High | 3.22 |
| 52-Week Low | 0.91 |
| Moving Average 50 Days | 1.21 |
| Moving Average 200 Days | 1.7 |
Statistics
| Average Volume | 153,322 |
| Shares Outstanding | 49.29M |
| % Held by Institutions | 17.04 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
